dr. I.S. Zuhorn
Non-viral gene delivery: intracellular trafficking of gene delivery devices, including lipoplexes and polyplexes. With a special focus on the mechanisms of endosomal escape of the genetic cargo.
Nanocarrier-mediated drug delivery to the brain: G23 peptide-mediated transcytosis of nanocarriers across the blood-brain barrier. Currently focusing on the design of nanocarriers for delivery of therapeutic (macro)molecules for the treatment of Alzheimer's disease, Multiple Sclerosis, Huntington's disease, and glioblastoma.
|Last modified:||04 February 2020 09.40 a.m.|